Failure of PGE1 to prevent liver allograft reperfusion injury in a prospective randomized trial.
Alevizacos
P
P
Department of Surgery, University Clinic Rudolf Virchow, Berlin, Germany.
Bechstein
W O
WO
Rossaint
R
R
Neuhaus
P
P
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000527:Alprostadil / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D005260:Female; D006801:Humans; D016031:Liver Transplantation / Q000401:mortality / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D015427:Reperfusion Injury / Q000517:prevention & control*; D016019:Survival Analysis; D013997:Time Factors; D014184:Transplantation, Homologous; D017211:Treatment Failure
D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000527:Alprostadil; D001663:Bilirubin